- Release Date: 07/07/25 16:03
- Summary: Notice under Section 708A
- Price Sensitive: No
- Download Document 267.78KB
- Forums
- ASX - By Stock
- PAR
- Ann: Notice under Section 708A
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
1.64%
!
30.0¢

Ann: Notice under Section 708A
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.0¢ |
Change
-0.005(1.64%) |
Mkt cap ! $119.2M |
Open | High | Low | Value | Volume |
31.0¢ | 31.0¢ | 30.0¢ | $74.35K | 243.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 312466 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.5¢ | 46353 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 313142 | 0.300 |
18 | 371112 | 0.295 |
21 | 337549 | 0.290 |
12 | 75421 | 0.285 |
11 | 259861 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.305 | 46353 | 6 |
0.310 | 59015 | 13 |
0.315 | 30695 | 6 |
0.320 | 27818 | 4 |
0.325 | 98750 | 6 |
Last trade - 13.59pm 22/08/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online